Jointly by 1. Edelweiss Alternative Asset Advisors Limited, 2. Esof III Investment Fund

CONFIDENTIAL

SUMMARY OF THE COMBINATION

[UNDER REGULATION 13(1A) OF THE COMPETITION COMMISSION OF INDIA (PROCEDURE IN REGARD TO THE TRANSACTION OF BUSINESS RELATING TO COMBINATIONS) REGULATIONS, 2011 (AS AMENDED)]

• (a) Name of the parties to the combination

1. The parties to the combination are:

• (i) Edelweiss Alternative Asset Advisors Limited (“ Acquirer 1 ”);

• (ii) ESOF III Investment Fund (“ Acquirer 2 ”); and

• (iii) Biocon Biologics Limited (“ Target ”).

1. Acquirer 1, Acquirer 2, and the Target are collectively referred to as the “ Parties ”.

• (b) The nature and purpose of the combination

1. Acquirer 1 and Acquirer 2 propose to subscribe to certain compulsorily convertible debentures issued by the Target (“ Proposed Combination ”). The Proposed Combination is notifiable to the Hon’ble Competition Commission of India under Section 5(a) of the Competition Act, 2002.